February 7, 2017
CMIC Holdings said on February 6 that OrphanPacific, its joint venture with Medipal Holdings, will distribute Diazoxide Capsules 25 mg “MSD”, a treatment for hyperinsulinemic hypoglycemia, beginning on April 1. CMIC Holdings, a Japanese CRO and CSO service provider, said...read more